HCM
$18.56
Revenue | $75.81Mn |
Net Profits | $-77.46Mn |
Net Profit Margins | -102.18% |
Hutchison China Meditech Limited’s revenue jumped 37.34% since last year same period to $75.81Mn in the Q2 2021. On a quarterly growth basis, Hutchison China Meditech Limited has generated 0% jump in its revenue since last 3-months.
Hutchison China Meditech Limited’s net profit fell -130.86% since last year same period to $-77.46Mn in the Q2 2021. On a quarterly growth basis, Hutchison China Meditech Limited has generated 0% jump in its net profits since last 3-months.
Hutchison China Meditech Limited’s net profit margin fell -68.09% since last year same period to -102.18% in the Q2 2021. On a quarterly growth basis, Hutchison China Meditech Limited has generated 0% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.42 |
EPS Estimate Current Year | -1.42 |
Hutchison China Meditech Limited’s earning per share (EPS) estimates for the current quarter stand at -1.42 - a -3334.62% fall from last quarter’s estimates.
Hutchison China Meditech Limited’s earning per share (EPS) estimates for the current year stand at -1.42.
Earning Per Share (EPS) | 0 |
Hutchison China Meditech Limited’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q4 2023. This indicates that the Hutchison China Meditech Limited has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-07-31 | -0.06 | 0.97 | 1863.64% |
2023-05-31 | -0.06 | 0 | 100% |
2024-02-29 | -1.42 | 0 | 100% |
2023-11-21 | 0.04 | 0 | -100% |